Galectin Therapeutics (GALT)
Develops belapectin, a galectin-3 inhibitor, for MASH cirrhosis with portal hypertension.
$4.35
Pre-market−0.14 (−3.12%)
At close$4.49(+7.67%)
Something off on this page? Send us feedback.
Next report
Nov 13, 2026
in 71 days
EPS estimate
−$0.05
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
May '25Aug '25Nov '25Mar '26May '26Aug '26Aug '26Nov '26
Reported−$0.15−$0.12−$0.13−$0.08−$0.08−$0.14−$0.14Pending
Estimate−$0.20−$0.16−$0.11−$0.10−$0.06−$0.09−$0.09−$0.05
Surprise+25.0%+25.0%−18.2%+20.0%−33.3%−55.6%−55.6%—
RevenueReportedEstimate
May '25Aug '25Nov '25Mar '26May '26Aug '26Aug '26Nov '26
Reported———————Pending
Estimate———$36.3M————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.05 | — | — |
| Aug 2026 | −$0.09 | −$0.14 | −55.6% |
| Aug 2026 | −$0.09 | −$0.14 | −55.6% |
| May 2026 | −$0.06 | −$0.08 | −33.3% |
| Mar 2026 | −$0.10 | −$0.08 | +20.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Nov 2025 | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Sep 2018 | |||
| Aug 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 13, 2026 | −$0.05 | — | — | — | — | — | — |
| Aug 14, 2026 | −$0.09 | −$0.14 | −55.6% | — | — | — | −2.6% |
| Aug 13, 2026 | −$0.09 | −$0.14 | −55.6% | — | — | — | +12.4% |
| May 15, 2026 | −$0.06 | −$0.08 | −33.3% | — | — | — | +0.9% |
| Mar 31, 2026 | −$0.10 | −$0.08 | +20.0% | $36.3M | — | — | −3.9% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||||||
| Nov 14, 2025 | |||||||
| Aug 14, 2025 | |||||||
| May 15, 2025 | |||||||
| Mar 31, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 13, 2024 | |||||||
| May 15, 2024 | |||||||
| Mar 29, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 15, 2023 | |||||||
| Mar 30, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 15, 2022 | |||||||
| May 16, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Aug 16, 2021 | |||||||
| May 17, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Nov 9, 2020 | |||||||
| Aug 10, 2020 | |||||||
| May 11, 2020 | |||||||
| Mar 16, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 9, 2019 | |||||||
| May 10, 2019 | |||||||
| Mar 6, 2019 | |||||||
| Nov 13, 2018 | |||||||
| Sep 28, 2018 | |||||||
| Aug 14, 2018 | |||||||
| Mar 29, 2018 | |||||||
| Nov 7, 2017 | |||||||
| Aug 14, 2017 | |||||||
| May 15, 2017 | |||||||
| Mar 28, 2017 | |||||||
| Nov 8, 2016 | |||||||
| Aug 9, 2016 | |||||||
| May 10, 2016 | |||||||
| Mar 15, 2016 | |||||||
| Nov 9, 2015 | |||||||